A detailed history of Kynam Capital Management, LP transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Kynam Capital Management, LP holds 8,826,710 shares of BCRX stock, worth $73.8 Million. This represents 4.25% of its overall portfolio holdings.

Number of Shares
8,826,710
Previous 6,527,491 35.22%
Holding current value
$73.8 Million
Previous $33.2 Million 64.51%
% of portfolio
4.25%
Previous 3.48%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.13 - $6.79 $9.5 Million - $15.6 Million
2,299,219 Added 35.22%
8,826,710 $54.5 Million
Q1 2024

May 15, 2024

BUY
$4.89 - $7.65 $9.43 Million - $14.7 Million
1,927,491 Added 41.9%
6,527,491 $33.2 Million
Q4 2023

Feb 14, 2024

BUY
$4.98 - $6.77 $7.3 Million - $9.93 Million
1,466,807 Added 46.82%
4,600,000 $27.6 Million
Q3 2023

Nov 14, 2023

BUY
$6.71 - $7.92 $1.91 Million - $2.26 Million
284,996 Added 10.01%
3,133,193 $22.2 Million
Q2 2023

Aug 14, 2023

BUY
$6.96 - $8.81 $12.9 Million - $16.3 Million
1,848,197 Added 184.82%
2,848,197 $20.1 Million
Q1 2023

May 15, 2023

BUY
$7.94 - $11.84 $7.94 Million - $11.8 Million
1,000,000 New
1,000,000 $8.34 Million
Q3 2022

Nov 14, 2022

SELL
$10.79 - $14.81 $5.41 Million - $7.43 Million
-501,446 Reduced 53.54%
435,117 $5.48 Million
Q2 2022

Aug 15, 2022

BUY
$7.89 - $17.88 $7.39 Million - $16.7 Million
936,563 New
936,563 $9.91 Million

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.55B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Kynam Capital Management, LP Portfolio

Follow Kynam Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Kynam Capital Management, LP with notifications on news.